Early treatment of COVID-19 crucial for patients with cancer
HEM/ONC Today
; 23(17):20, 2022.
Article
in English
| ProQuest Central | ID: covidwho-2167821
ABSTRACT
More than 2 years after the COVID-19 pandemic began, new treatments, vaccines and preventive measures have improved safety and disease outcomes for patients with cancer, according to a keynote lecture. In her lecture, Kamboj addressed frequently asked questions about various aspects of COVID-19 vaccination, testing and treatment among patients with cancer. When considering which patients with cancer might be eligible for revaccination, Kamboj said clinicians should think about those who received B-cell depleting therapies, chimeric antigen receptor T-cell therapy and stem cell transplant, when there is evidence of immune reconstitution.
Search on Google
Collection:
Databases of international organizations
Database:
ProQuest Central
Language:
English
Journal:
ONC Today
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS